The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,717.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,708,643 units of the contraceptive implant NEXPLANON 68 MG by January 2, 2025.
This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has a proven track record of providing a diverse array of pharmaceutical products to the DLA.
Generated 3/11/25, 9:46 AM